Crinetics Pharmaceuticals Stock Analysis

Crinetics Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Crinetics Pharmaceuticals was currently reported as 10.3. The company recorded a loss per share of 3.7. Crinetics Pharmaceuticals had not issued any dividends in recent years. Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California. Crinetics Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 143 people. For more info on Crinetics Pharmaceuticals please contact Scott Struthers at 858 450 6464 or go to https://www.crinetics.com.

Crinetics Pharmaceuticals Investment Alerts

Crinetics Pharmaceuticals Upcoming and Recent Events

Crinetics Largest EPS Surprises

View All Earnings Estimates

Crinetics Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Crinetics Stock Institutional Investors

Note, although Crinetics Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Crinetics Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.27 B.

Crinetics Profitablity

Management Efficiency

Crinetics Pharmaceuticals has return on total asset (ROA) of (0.2429) % which means that it has lost $0.2429 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4026) %, meaning that it created substantial loss on money invested by shareholders. Crinetics Pharmaceuticals' management efficiency ratios could be used to measure how well Crinetics Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.32 in 2025. Return On Capital Employed is likely to drop to -0.36 in 2025. At this time, Crinetics Pharmaceuticals' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 382 M in 2025, whereas Other Assets are likely to drop 1.09 in 2025.

Technical Drivers

As of the 16th of February 2025, Crinetics Pharmaceuticals shows the Mean Deviation of 2.49, standard deviation of 3.46, and Risk Adjusted Performance of (0.15). Crinetics Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Crinetics Pharmaceuticals Price Movement Analysis

Crinetics Pharmaceuticals Insider Trading Activities

Crinetics Pharmaceuticals Outstanding Bonds

Crinetics Pharmaceuticals Predictive Daily Indicators

Crinetics Pharmaceuticals Corporate Filings

Crinetics Pharmaceuticals Forecast Models

Crinetics Pharmaceuticals' time-series forecasting models are one of many Crinetics Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Crinetics Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Crinetics Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Crinetics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Crinetics Pharmaceuticals. By using and applying Crinetics Stock analysis, traders can create a robust methodology for identifying Crinetics entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Crinetics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Crinetics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Crinetics Pharmaceuticals stock analysis indicators help investors evaluate how Crinetics Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Crinetics Pharmaceuticals shares will generate the highest return on investment. By understating and applying Crinetics Pharmaceuticals stock analysis, traders can identify Crinetics Pharmaceuticals position entry and exit signals to maximize returns.

When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.